![hVEGF-IN-1 ol-7-O-β-D-glucopyranoside 4-tetrahydroquinazolin-2-ylidene]propanenitrile](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M19735_1635189442.gif?v=1635189443)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
4-tetrahydroquinazolin-2-ylidene]propanenitrile
LG100754 is an insulin sensitizer that functions through RXR
Formula: C18H14F4N2O4S
Brasofensine
Chemical Name: (3S)-3-{[(1S)-1-{[(1S)-1-{[(1S
hVEGF-IN-1 ol-7-O-β-D-glucopyranoside 4-tetrahydroquinazolin-2-ylidene]propanenitrilehVEGF IN 1, a quinazoline derivative, could specifically bind to the G rich sequence in the internal ribosome entry site A (IRES A) and destabilize the G quadruplex structure. hVEGF IN 1 binds to the IRES A (WT) with a Kd of 0. 928 M in SPR experiments. hVEGF IN 1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF A protein expression. Product information CAS Number: 1637443 98 1 Molecular Weight: 581. 75 Formula:
US$ 16.00
US$ 50.00
US$ 13.00
US$ 33.00
US$ 95.00